Management of hemorrhagic events in patients receiving anticoagulant therapy

Journal of Thrombosis and Thrombolysis

Volumn 7, Issue 2, 1999, Pages 149-152

  Love, Donald G ^a,b  

^a HARVARD UNIVERSITY   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTICOAGULANT AGENT; FIBRINOLYTIC AGENT; FRESH FROZEN PLASMA; HEPARIN; PHYTOMENADIONE; PROTAMINE; VITAMIN K GROUP;

ANTICOAGULANT THERAPY; BLEEDING; BLOOD TRANSFUSION; HUMAN; PRIORITY JOURNAL; RISK FACTOR; SHORT SURVEY; THROMBOCYTE;

ANTICOAGULANTS; BLOOD COMPONENT TRANSFUSION; DRUG INTERACTIONS; HEMORRHAGE; HEPARIN; HEPARIN ANTAGONISTS; HUMANS; INCIDENCE; PLASMA; PLATELET TRANSFUSION; PRACTICE GUIDELINES; PROTAMINES; RISK FACTORS; VITAMIN K; WARFARIN;

EID: 0032908970     PISSN: 09295305     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1008885504228     Document Type: Short Survey

References (12)

1. Levine MN. Hemorrhagic complications of anticoagulant treatment. Chest 1995;108:276S-290S.
2. Landefeld CS. Rosenblatt MW, Goldman L. Bleeding in outpatients treated with warfarin: Relation to the prothrombin time and important remediable lesions. Am J Med 1989;87:144-152.
3. Levine M, Goldhaber SZ, Gore JM. Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism. Chest 1995;108:291S-301S.
4. Weitz J, Califf RKM, Ginsberg JS, Hirsh J, Theroux P, New antithrombotics. Chest 1995;108:471S-485S.
5. Landefeld S, Beyeth R. Anticoagulant-Related Bleeding: Clinical epidemiology, prediction, and prevention. Am J Med 1993;95:315-328.
6. Julius C, Westphal RG. The safety of blood components and derivative. Hematol Oncol North Am 1992;6:1057-1077.
7. Hirsh J. Oral anticoagulants, mechanism of action, clinical effectiveness, and optimal therapeutic range. Chest 1995;108:231S-246S.
8. Brophy MT, Fiore LD, Deykin D. Low-dose Vitamin K therapy in excessively anticoagulated patients: A dose-finding study. J Thromb Thrombos 1997;4:289-292.
9. Martin JC. Anaphylactoid reactions and vitamin K. Med J Aust 1991;155:851.
10. Lefrere JJ, Girot R. Acute cardiovascular collapse during intravenous vitamin K injection. Thromb Haemost 1987;58:790.
11. Rich EC, Drage CW. Severe complications of intravenous phytonadione therapy - Two cases, with one fatality. Postgard Med J 1982;72:303-306.
12. Fernandez F, Nguyen P. van Ryn J, et al. Hemorrhagic doses of heparin and other glycosaminoglycans induce a platelet defect. Thromb Res 1986;43:491-495.